Bausch Health Companies | Nettoeinkommen

Aktienkurs
8.03
Täglich Wechseln
0.19 2.42%
Monatlich
-26.67%
Jährlich
-13.00%
Q1 Prognose
7.84




Nettoeinkommen Veränderung Datum
Amgen USD 1.33B 1.88B 2025-12
ANI Pharmaceuticals USD 26.27M 18.13M 2025-09
Aurora Cannabis CAD -51.47M 36.26M 2025-09
Bausch Health Companies USD 179M 31M 2025-09
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -1.64M 39.89M 2025-09
Corcept Therapeutics USD 19.67M 15.48M 2025-09
Danaher USD 1.2B 289M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 3.05B 1.09B 2025-09
Novo Nordisk DKK 26.89B 388M 2025-12
Pacira USD 5.43M 10.28M 2025-09
Perrigo USD 7.5M 15.9M 2025-09
Prestige Brands USD 46.7M 22.44M 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09
Zoetis USD 721M 3M 2025-09


Bausch Health Companies Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.